Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Consolidated Net Income (2021 - 2025)

Historic Consolidated Net Income for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$2.4 million.

  • HeartSciences' Consolidated Net Income fell 1190.44% to -$2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$9.1 million, marking a year-over-year decrease of 1701.1%. This contributed to the annual value of -$8.9 million for FY2025, which is 3293.13% down from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Consolidated Net Income is -$2.4 million, which was down 1190.44% from -$2.1 million recorded in Q3 2025.
  • HeartSciences' 5-year Consolidated Net Income high stood at -$752051.0 for Q3 2021, and its period low was -$2.6 million during Q1 2025.
  • Its 5-year average for Consolidated Net Income is -$1.7 million, with a median of -$1.8 million in 2022.
  • In the last 5 years, HeartSciences' Consolidated Net Income plummeted by 10925.5% in 2022 and then surged by 2054.79% in 2023.
  • Over the past 5 years, HeartSciences' Consolidated Net Income (Quarter) stood at -$1.0 million in 2021, then tumbled by 74.7% to -$1.8 million in 2022, then grew by 3.28% to -$1.7 million in 2023, then fell by 20.26% to -$2.1 million in 2024, then decreased by 11.9% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q4 2025, -$2.1 million for Q3 2025, and -$2.1 million during Q2 2025.